Abstract
This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Current Pharmacogenomics and Personalized Medicine
Title:Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries
Volume: 10 Issue: 4
Author(s): Victor P. Andreev
Affiliation:
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Abstract: This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Export Options
About this article
Cite this article as:
Andreev P. Victor, Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries, Current Pharmacogenomics and Personalized Medicine 2012; 10 (4) . https://dx.doi.org/10.2174/187569212803901747
DOI https://dx.doi.org/10.2174/187569212803901747 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pentacyclic Triterpenoids and Their Saponins with Apoptosis-Inducing Activity
Current Topics in Medicinal Chemistry Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets Antidiabetics: Structural Diversity of Molecules with a Common Aim
Current Medicinal Chemistry The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry Thioethers: An Overview
Current Drug Targets Advanced Microfluorescence Methods in Monitoring Intracellular Uptake of “Antisense” Oligonucleotides
Current Organic Chemistry Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
Recent Patents on Anti-Cancer Drug Discovery Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer
Current Angiogenesis (Discontinued) Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents
Current Bioinformatics Long Noncoding RNA C21orF96 Promotes the Migration, Invasion and Lymph Node Metastasis in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Regulation of Autophagy by Sphingolipids
Anti-Cancer Agents in Medicinal Chemistry Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Regenerative Potential of Stem Cell-derived Extracellular Vesicles in Spinal Cord Injury (SCI)
Current Stem Cell Research & Therapy Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Current Pharmaceutical Design Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Histone Deacetylase Inhibitors in Tumor Immunotherapy
Current Medicinal Chemistry Synthetic Peptides for the Immunodiagnosis of Human Diseases
Current Medicinal Chemistry